4//SEC Filing
Lu Hongbo 4
Accession 0001562180-22-008428
CIK 0001831363other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 5:44 PM ET
Size
5.3 KB
Accession
0001562180-22-008428
Insider Transaction Report
Form 4
Lu Hongbo
Director
Transactions
- Purchase
Common Stock
2022-12-23$7.25/sh+758,620$5,499,995→ 4,340,212 total(indirect: See Footnote)
Footnotes (1)
- [F1]The securities are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P. As a managing member of Vivo Opportunity, LLC, Hongbo Lu shares voting and dispositive power over the securities held by Vivo Opportunity Fund Holdings, L.P. with four other managing members but disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein.
Documents
Issuer
Terns Pharmaceuticals, Inc.
CIK 0001831363
Entity typeother
Related Parties
1- filerCIK 0001767584
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 5:44 PM ET
- Size
- 5.3 KB